Wow a one pager update. I guess with all the fails, that’s all they got. What was this line? “An additional clinical hematological study is anticipated later this year.” They couldn’t name the trial by name. Or is it a preclinical trial they’re proudly boasting about. But again, ambiguity is best.
Well done Kaki. Another slap in the face to your employers aka shareholders.
News 
Market Data 
Discover 
AI
